ValuEngine upgraded shares of Vitamin Shoppe (NYSE:VSI) from a buy rating to a strong-buy rating in a report published on Tuesday.
Separately, Zacks Investment Research raised shares of Vitamin Shoppe from a sell rating to a hold rating in a research note on Wednesday, May 16th.
VSI opened at $12.30 on Tuesday. The company has a quick ratio of 0.32, a current ratio of 1.96 and a debt-to-equity ratio of 0.32. The company has a market cap of $307.88 million, a P/E ratio of 31.67 and a beta of 0.74. Vitamin Shoppe has a fifty-two week low of $2.95 and a fifty-two week high of $13.95.
Vitamin Shoppe (NYSE:VSI) last posted its quarterly earnings results on Wednesday, August 8th. The specialty retailer reported $0.31 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.04 by $0.27. The business had revenue of $293.10 million during the quarter, compared to the consensus estimate of $279.87 million. Vitamin Shoppe had a negative net margin of 8.76% and a positive return on equity of 2.42%. equities research analysts anticipate that Vitamin Shoppe will post 0.13 earnings per share for the current fiscal year.
In other Vitamin Shoppe news, Director Guillermo Marmol purchased 8,900 shares of the company’s stock in a transaction that occurred on Friday, August 10th. The stock was acquired at an average cost of $11.21 per share, with a total value of $99,769.00. Following the completion of the purchase, the director now directly owns 49,479 shares in the company, valued at approximately $554,659.59. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Sharon M. Leite acquired 5,500 shares of the firm’s stock in a transaction that occurred on Friday, August 31st. The shares were purchased at an average price of $12.64 per share, with a total value of $69,520.00. Following the acquisition, the chief executive officer now owns 5,500 shares of the company’s stock, valued at approximately $69,520. The disclosure for this purchase can be found here. Insiders own 18.50% of the company’s stock.
Hedge funds and other institutional investors have recently modified their holdings of the stock. Trexquant Investment LP acquired a new position in Vitamin Shoppe during the second quarter valued at approximately $105,000. GSA Capital Partners LLP acquired a new position in Vitamin Shoppe during the first quarter valued at approximately $109,000. Nisa Investment Advisors LLC acquired a new position in Vitamin Shoppe during the second quarter valued at approximately $129,000. Spark Investment Management LLC acquired a new position in Vitamin Shoppe during the second quarter valued at approximately $227,000. Finally, AJ Wealth Strategies LLC acquired a new position in Vitamin Shoppe during the second quarter valued at approximately $266,000. Hedge funds and other institutional investors own 89.62% of the company’s stock.
Vitamin Shoppe Company Profile
Vitamin Shoppe, Inc, through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded products.
Read More: How to Use a Moving Average for Trading
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.